In MI Clopidogrel reloading does not increase risk of in-hospital major bleeding or mortality Dr. Kamal Kant Kohli Kohli8 Oct 2017 10:30 AM ISTClopidogrel reloading occurs most frequently in patients with acute myocardial infarction (MI) who are already taking clopidogrel, particularly for...
How SORLA protects against Alzheimer disease Anjali Nimesh Nimesh9 Nov 2017 7:00 PM ISTResearchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) have identified a new protective function for a brain protein genetically...
New pain treatment tested in humans Anjali Nimesh Nimesh28 Nov 2017 7:18 PM ISTNerve growth factor signals through receptors of the tropomyosin-related kinase (Trk) family and research in animals has shown that inhibitors of Trks...
Acupuncture significantly reduces joint pain in breast cancer patients Anjali Nimesh Nimesh8 Dec 2017 7:00 PM ISTIn the largest, most rigorous study of its kind, acupuncture was found to significantly reduce the debilitating joint pain experienced by tens of...
New Therapies Improve Outlook for Bleeding and Clotting Disorders Dr. Kamal Kant Kohli Kohli11 Dec 2017 7:25 PM ISTIn three studies presented during the 59th American Society of Hematology (ASH) Annual Meeting and Exposition in Atlanta, researchers report...
Third of people not taking their prescribed diabetes medication due to side effects Anjali Nimesh Nimesh18 Dec 2017 7:03 PM ISTDiabetes patients who take the most commonly prescribed diabetes drug, metformin, are the least likely to follow medical advice regarding their...
U.S. FDA approves new diabetes drug from Merck and Pfizer Anjali Nimesh Nimesh22 Dec 2017 7:05 PM ISTA new drug developed by Merck & Co and Pfizer Inc won U.S. approval on Wednesday to treat type II diabetes, the Food and Drug Administration said,...
New combination therapy found effective in ovarian cancer Anjali Nimesh Nimesh23 Dec 2017 7:15 PM ISTResearchers at The Wistar Institute have found that combining PARP inhibitors, recently approved for the treatment of BRCA-mutant ovarian cancer, with...
Carfilzomib can lead to cardiovascular toxicity in multiple myeloma patients Anjali Nimesh Nimesh29 Dec 2017 7:10 PM IST The proteasome inhibitor carfilzomib has taken on an increasing role in the treatment of multiple myeloma, but new research from the Abramson Cancer...
Twice-weekly workouts may be best medicine for cognitive decline Anjali Nimesh Nimesh7 Jan 2018 7:00 PM ISTThere’s little evidence that medications improve mild cognitive decline associated with aging, according to a new review of research, but doctors can...
ADA Guidelines for treating Hypertension with Diabetes Dr. Kamal Kant Kohli Kohli7 Feb 2018 7:01 PM ISTAmerican Diabetes Association has released guidelines for treatment of Hypertension in Patients with Diabetes which have been published in Diabetes...
Cabozantinib a first line treatment option for differentiated thyroid cancer Anjali Nimesh Nimesh15 Feb 2018 7:10 PM ISTIn a trial by the Abramson Cancer Center and the Perelman School of Medicine at the University of Pennsylvania,it has been confirmed that...
